c-Met kinase inhibitors (Fudan University/Chinese Academy of Sciences)

N/A

Report date: 2025/03/18 18:12:24
NME

Base Information

Drug Namec-Met kinase inhibitors (Fudan University/Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFudan University Shanghai Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesFudan University Shanghai Cancer CenterChinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A